{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:35:47Z","timestamp":1765485347927},"reference-count":28,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Ethics"],"published-print":{"date-parts":[[2009,2]]},"abstract":"Background:<\/jats:title>As there is little Indian data about severity, frequency and types of research related injuries, costs involved and policies regarding compensation, this study was conducted to review the present Indian scenario.<\/jats:p><\/jats:sec>Methods:<\/jats:title>The study was carried out in three parts; a questionnaire-based survey, in-depth interviews, and a review of informed consent and insurance documents of projects submitted to three ethics committees.<\/jats:p><\/jats:sec>Results:<\/jats:title>47% of investigators were either unaware of, or had not understood, the legal requirements and depended on sponsors to manage these issues, whereas 74% of ethics committee members were aware of the requirements. Although 40% of investigators, 30% of ethics committee members and all sponsors had policies to manage compensation issues, these were mainly to provide immediate free medical care or reimbursement of expenses incurred for the acute management of an adverse event. Compensation for loss of time\/wages, death, physical disability or long term incapacitation was not included. A review of informed consent and insurance documents showed that compensation issues were inadequately discussed, with only insurance certificates submitted to ethics committees.<\/jats:p><\/jats:sec>Conclusion:<\/jats:title>In India, there are no uniform policies and investigators are largely unaware of their responsibilities. Therefore, there is an urgent need to draft national guidelines regarding compensation for research injuries of research participants and highlight the responsibilities of each stakeholder. Potential research injuries should be categorised based on risk assessment, severity and seriousness of the injury. Further, it would be necessary to have arbitration committees to determine the extent of compensation. Training and awareness workshops for those involved in clinical research, including research participants, is also needed.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jme.2008.025155","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T19:59:59Z","timestamp":1233345599000},"page":"133-139","source":"Crossref","is-referenced-by-count":10,"title":["Review of policies for injuries to research participants in India"],"prefix":"10.1136","volume":"35","author":[{"given":"U M","family":"Thatte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kulkarni-Munshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Kalekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2009,1,30]]},"reference":[{"key":"2024052300434109000_35.2.133.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38797.635012.47"},{"key":"2024052300434109000_35.2.133.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068080"},{"key":"2024052300434109000_35.2.133.3","unstructured":"National Institute of Health; Office of the Human Subject Research. OHSR information sheets\/forms. http:\/\/ohsr.od.nih.gov\/info\/sheet6.html (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.4","unstructured":"Statutory Instrument 2004 No. 1031 The medicines for human use (clinical trials) regulations 2004. http:\/\/www.opsi.gov.uk\/si\/si2004\/20041031.htm (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.5","unstructured":"Amended Schedule Y (Drugs and Cosmetics Act (2nd Amendment) Rules . 20 January 2005, New Delhi. See http:\/\/www.cdsco.nic.in\/html\/Schedule-Y%20(Amended%20Version-2005)%20original.htm (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.6","unstructured":"Central Drugs Standard Control Organization. Good clinical practices for clinical research in India. December 2001 http:\/\/cdsco.nic.in\/html\/GCP.htm (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.7","unstructured":"Indian Council of Medical Research (ICMR). Ethical guidelines for biomedical research on human subjects. 2000. http:\/\/www.icmr.nic.in\/buoct2000.htm (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.8","unstructured":"Indian Council of Medical Research (ICMR). Ethical Guidelines for Biomedical Research on Human Subjects. 2006 http:\/\/www.icmr.nic.in\/ethical.pdf (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bmj.332.7541.610","article-title":"Paying for research related injuries in the US.","volume":"332","author":"Hochhauser","year":"2006","journal-title":"BMJ"},{"key":"2024052300434109000_35.2.133.10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/bmj.332.7539.489-b","article-title":"Compensation for non-negligent harm in trials remains shaky.","volume":"332","author":"Laurence","year":"2006","journal-title":"BMJ"},{"key":"2024052300434109000_35.2.133.11","doi-asserted-by":"crossref","unstructured":"Marwick C . Compensation for injured research subjects JAMA 1998;279:1854.","DOI":"10.1001\/jama.279.23.1854-JMN0617-2-1"},{"key":"2024052300434109000_35.2.133.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.03.045"},{"key":"2024052300434109000_35.2.133.13","doi-asserted-by":"publisher","DOI":"10.1080\/01947640600870866"},{"key":"2024052300434109000_35.2.133.14","unstructured":"The Lewin Group. Task order proposal no. 2: care\/compensation for injuries in clinical research. Draft of the final report prepared for the Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation. Falls Church, Va.: The Lewin Group, May 18, 2005 (Contract no.HHS 100-03-0005.)"},{"key":"2024052300434109000_35.2.133.15","unstructured":"United States Department of Health and Human Services Code of Federal Regulations (CFR) Part 46 . Protection of human subjects. Section 116. http:\/\/www.hhs.gov\/ohrp\/humansubjects\/guidance\/45cfr46.htm (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.2003.tb00106.x"},{"key":"2024052300434109000_35.2.133.17","doi-asserted-by":"crossref","unstructured":"Gaine WJ . No-fault compensation systems. BMJ 2003 May 10;326:997\u00e2\u0080\u00938.","DOI":"10.1136\/bmj.326.7397.997"},{"key":"2024052300434109000_35.2.133.18","unstructured":"The Medical Product Agency\u00e2\u0080\u0099s provisions and guidelines on clinical trials of medicinal products for human use, Sweden . http:\/\/www.lakemedelsverket.se\/Tpl\/NormalPage____2159.aspx (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.19","unstructured":"Regulation relating to clinical trials on medicinal products for human use (FOR 2003-09-24 nr 1202), Norway. http:\/\/www.legemiddelverket.no\/upload\/31448\/FOR%202003-09-24%20nr%201202%20english.pdf (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.20","unstructured":"Medical Research Act, Finland. Ethical evaluation of research in Finland. http:\/\/www.tenk.fi\/ENG\/Publicationsguidelines\/EthicalEvaluationofResearchinFinland.pdf (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.21","unstructured":"Act on a Biomedical Research Ethics Committee System and the Processing of Biomedical Research Projects, Denmark . http:\/\/www.cvk.im.dk\/cvk\/site.aspx?p\u00e2\u0080\u008a=\u00e2\u0080\u008a150 (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.22","unstructured":"ABPI Guidelines for Phase I studies 2007 edition . http:\/\/www.abpi.org.uk\/publications\/pdfs\/phase1_guidelines.pdf (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.23","unstructured":"ABPI guidelines for phase II\/III studies . Clinical trials compensation guidelines. http:\/\/www.abpi.org.uk\/publications\/pdfs\/Clinical-Trial-Compensation-GLs.pdf (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.24","unstructured":"The Clinical Trials Committee of the South African Medicines Control Council. Appendix IV: clinical trial compensation guidelines. http:\/\/www.sahealthinfo.org\/ethics\/book1appen4.htm (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.25","unstructured":"Guidelines for Compensation for Injury resulting from participation in a company sponsored clinical trial, Australia . http:\/\/www.medicinesaustralia.com.au\/pages\/images\/Clnical%20Trials%20Compensation%20Guidelines.pdf (accessed 29 Oct 2008)."},{"key":"2024052300434109000_35.2.133.26","unstructured":"Researched Medicines Industry. Guidelines on clinical trials compensation for injury resulting from participation in an industry-sponsored clinical trial. http:\/\/www.rmianz.co.nz\/compensation%20guidelines%200808%20final.pdf (accessed 11 Nov 2008)."},{"key":"2024052300434109000_35.2.133.27","doi-asserted-by":"publisher","DOI":"10.1136\/jme.23.3.181"},{"key":"2024052300434109000_35.2.133.28","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.25.1.278"}],"container-title":["Journal of Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jme.2008.025155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T09:31:48Z","timestamp":1716456708000},"score":1,"resource":{"primary":{"URL":"https:\/\/jme.bmj.com\/lookup\/doi\/10.1136\/jme.2008.025155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,30]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,1,30]]},"published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1136\/jme.2008.025155"],"URL":"https:\/\/doi.org\/10.1136\/jme.2008.025155","relation":{},"ISSN":["0306-6800","1473-4257"],"issn-type":[{"value":"0306-6800","type":"print"},{"value":"1473-4257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,30]]}}}